Press

Press and
Media Center.

AXIONOVA™ is a precision bio-science and longevity platform for practitioners, clinics, and qualified healthcare organizations. Media and partner requests are routed for human review before publication.

Hi, I am ALETHA. I help you understand your data and prepare it for your practitioner. I do not make clinical decisions; your practitioner does.

ALETHRA™ governs; ALETHA™ guides. The governance model

About AXIONOVA™ for Journalists

Precision bio-science,
governed for human optimization.

AXIONOVA™ develops physician-directed biological systems that connect compound identity, protocol logic, governed delivery (AXIS), and continuous physiology (AXIONOVA™ Ring and Bracelet) into one controlled model. ALETHRA™ governs the system. ALETHA™ guides the experience. Learn more

Regulatory note · AXIONOVA™ compounds and related materials are compounded medications prepared by licensed pharmacies pursuant to valid prescriptions. Compounded medications are not FDA-approved. All clinical decisions are made by licensed physicians.

Media Requests

Routed for human review
before publication.

A human team reviews every media inquiry before any statement is published. AXIONOVA™ does not authorize disease, therapeutic, or performance claims, and public statements stay within physician-directed compliance boundaries.

Communications · Powered by ALETHRA™

Transparency in system governance.

Press communications are logged under ALETHRA™ for provenance and audit. Reach the communications office directly.